Molecular genetic evidence for the conversion hypothesis of the origin of malignant mixed Müllerian tumours

The origin of malignant mixed Müllerian tumours (MMMTs) has long been debated, due to the indefinite relationship between epithelial and mesenchymal malignant cells. In order to obtain insight into the clonal relationship between the two components of these tumours, molecular genetic changes were investigated at the level of loss of heterozygosity (LOH) in both cells types. LOH was studied in a series of six cases with 74 polymorphic microsatellite markers mapping to 19 different chromosomes. The epithelial and the mesenchymal neoplastic cells were separately microdissected from formalin‐fixed, paraffin‐embedded tissue, prior to DNA isolation. LOH was observed for 35 different markers mapping to chromosomes 3, 6, 8, 11, 15, 16, 17, 18, 21, and X. The most frequently involved chromosomes were 17p, 17q, 11q, 15q, and 21q. LOH was observed in five out of six cases and identical alleles were lost in the epithelial and in the mesenchymal cells. No genetic differences were observed between the two cell types for any of the informative markers. Immunohistochemistry (IHC) and TP53 mutation analysis revealed involvement of TP53 in all cases. Mutations were identified in five MMMTs. In four tumours, of which three had a missense mutation, strong nuclear staining for p53 was observed. In the remaining two cases, the mutation resulted in a stop codon, with no nuclear staining for p53 by IHC. The results support a monoclonal origin of MMMTs, with the absence of genetic changes uniquely associated with either of the phenotypes. The latter finding is compatible with current opinion that these neoplasms should be considered as metaplastic carcinomas and supports the conversion hypothesis. © 1997 John Wiley & Sons, Ltd.

[1]  N. Hayward,et al.  Relevance of ultraviolet-induced N-ras oncogene point mutations in development of primary human cutaneous melanoma. , 1996, The American journal of pathology.

[2]  M. Sherman,et al.  p53 in endometrial cancer and its putative precursors: evidence for diverse pathways of tumorigenesis. , 1995, Human pathology.

[3]  M. Sherman,et al.  Endometrial intraepithelial carcinoma: a distinctive lesion specifically associated with tumors displaying serous differentiation. , 1995, Human pathology.

[4]  W. R. Hart,et al.  Carcinosarcomas of the female genital tract. A pathologic study of 29 metastatic tumors: further evidence for the dominant role of the epithelial component and the conversion theory of histogenesis. , 1995, The American journal of surgical pathology.

[5]  M. Costa,et al.  p53 gene mutation in female genital tract carcinosarcomas (malignant mixed müllerian tumors): a clinicopathologic study of 74 cases. , 1994, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[6]  F. Campbell,et al.  p53 immunostaining suggests that uterine carcinosarcomas are monoclonal , 1994, Histopathology.

[7]  G. van Ommen,et al.  Detection of the t(14,18) Translocation in Frozen and Formalin‐fixed Tissue , 1993, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[8]  H. Iwasaki,et al.  Characteristics of cloned cells of mixed müllerian tumor of the human uterus carcinoma cells showing myogenic differentiation in vitro , 1993, Cancer.

[9]  J. Orenstein,et al.  Carcinosarcoma (malignant mixed müllerian (mesodermal) tumor) of the female genital tract: immunohistochemical and ultrastructural analysis of 28 cases. , 1993, Human pathology.

[10]  P. Humphrey,et al.  Clonal origin of epithelial ovarian carcinoma: analysis by loss of heterozygosity, p53 mutation, and X-chromosome inactivation. , 1992, Journal of the National Cancer Institute.

[11]  Bert Vogelstein,et al.  p53 function and dysfunction , 1992, Cell.

[12]  S. Hirohashi,et al.  Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas. , 1991, Cancer research.

[13]  J. Mattick,et al.  'Touchdown' PCR to circumvent spurious priming during gene amplification. , 1991, Nucleic acids research.

[14]  M. Wick,et al.  Malignant mixed müllerian tumors: an immunohistochemical study of 47 cases, with histogenetic considerations and clinical correlation. , 1991, Human pathology.

[15]  P. Devilee,et al.  Frequent somatic imbalance of marker alleles for chromosome 1 in human primary breast carcinoma. , 1991, Cancer research.

[16]  R. Kurman,et al.  The Significance of Epithelial Differences in Mixed Mesodermal Tumors of the Uterus: A Clinicopathologic and Immunohistochemical Study , 1990, The American journal of surgical pathology.

[17]  J. Weber,et al.  Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction. , 1989, American journal of human genetics.

[18]  D. de Jong,et al.  Analysis of tumor heterogeneity in a patient with synchronously occurring female genital tract malignancies by DNA flow cytometry, dna fingerprinting, and immunohistochemistry , 1988, Cancer.

[19]  H. Oberman Metaplastic Carcinoma of the Breast : A Clinicopathologic Study of 29 Patients , 1987, The American journal of surgical pathology.

[20]  G. Ellis,et al.  Spindle-Cell Carcinoma of the Aerodigestive Tract: An Immunohistochemical Analysis of 21 Cases , 1987, The American journal of surgical pathology.

[21]  R. Goudie,et al.  Epithelial antigens in malignant mixed Müllerian tumours of endometrium , 1986, The Journal of pathology.

[22]  F. Vellios,et al.  Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus. , 1963, American journal of clinical pathology.

[23]  M. Guarino Epithelial-to-mesenchymal change of differentiation. From embryogenetic mechanism to pathological patterns. , 1995, Histology and histopathology.

[24]  H. Echols,et al.  Fidelity mechanisms in DNA replication. , 1991, Annual review of biochemistry.

[25]  F. Askin,et al.  Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus. A Gynecologic Oncology Group pathologic study of 203 cases. , 1990, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.